Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 3/20 | 0.35 |
| ▸ | CNR2 | P34972 | 3/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 8/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24349440 | 0.78 | CA1 (0.34) | LMNAALDH1A1MAPTCNR1CNR2 | |
| SCHEMBL29104732 | 0.69 | CA1 (0.41) | LMNAALDH1A1MAPTTSHRHTT | |
| SCHEMBL8763566 | 0.66 | ALDH1A1 (0.43) | LMNAALDH1A1MAPTHTT | |
| SCHEMBL656155 | 0.65 | PTGS2 (0.42) | LMNAALDH1A1MAPTSMN1; SMN2TSHR | |
| SCHEMBL27432349 | 0.65 | CA1 (0.38) | LMNAALDH1A1MAPTSMN1; SMN2TSHR | |
| SCHEMBL8089603 | 0.65 | MEN1 (0.38) | LMNAALDH1A1MAPTSMN1; SMN2TSHR | |
| SCHEMBL16461465 | 0.64 | KMT2A (0.38) | LMNAALDH1A1MAPTTSHR | |
| SCHEMBL658620 | 0.63 | ALDH1A1 (0.40) | LMNAALDH1A1MAPTSMN1; SMN2HTT | |
| SCHEMBL8076428 | 0.63 | ALDH1A1 (0.37) | LMNAALDH1A1MAPTCNR1CNR2 | |
| SCHEMBL25686065 | 0.63 | LMNA (0.41) | LMNAALDH1A1MAPTSMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200209741-A1 | RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, POLYMERIC COMPOUND, AND COMPOUND | TOKYO OHKA KOGYO CO., LTD. (JP) | 2020-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200209741-A1 | RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, POLYMERIC COMPOUND, AND COMPOUND | RER1, SERPINB10, ABCC1 | LMNA 1628/4885ALDH1A1 684/4885MAPT 3423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.